Dislipidemias in Patients with Cardiopathy Isquemica
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2013, Vol 2, Issue 2
Abstract
The dislipidemias are a risk factor well recognized of the cardiovascular diseases and constitute a problem of public health. A descriptive study in 150 patient elders of 30 years with diagnosis of Izquemic Cardiopathyes accomplished itself for the sake of identifying dislipidemias in patients of high cardiovascular risk that they helped the high-technology General Medical Center state James Mariño Aragua, at the Republic Bolivariana of Venezuela, that you constituted the sign of study from October 2011 to October 2012. They used quantitative and qualitative variables like weight, age, sex, pathological personal background, risk factors cardiovascular associates, seric levels of total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol VLDL cholesterol. 63 percent of patients with dislipidemias were detected, being hypercholesterolemia the more alteration frequently found. The ages understood between 41 and 60 years evidenced the bigger frequency.
Authors and Affiliations
Dalyla Alonso Rodríguez
Keywords
Related Articles
- EP ID EP201574
- DOI 10.19070/2167-910X-1300011
- Views 65
- Downloads 0
Population Pharmacokinetic Analysis of Alcohol Concentration after Beer Consumption in Fasted Japanese Subjects
The absorption rate of alcohol is one of the determinants of the peak blood alcohol concentration. Studies focusing on factors that cause inter-individual variability in absorption rate have not been conducted. To conduc...
Anticancer Agents: A Review of Relevant Information on Important Herbal Drugs
Cancer has almost created havoc amongst the human society as the number of mortalities is increasing day-by-day and year after year. Numerous studies have been done to find out the cure for cancer but to no avail. Herbal...
PPAR α/γ Agonist in Management of Diabetic Dyslipidemia: A Review
Cardiovascular diseases are major contributors of mortality and morbidity in patients with type 2 diabetes mellitus (T2DM), while dyslipidemia and hyperglycemia are key modifiable risk factors to prevent coronary artery...
Protective Effect of Montelukast against Cadmium Induced Pituitary Gland Toxicity
Cadmium (Cd) is a common environmental hazardous heavy metal. The standard treatment of heavy metal intoxication;chelators may have a minor role in Cd toxicity. Montelukast (ML) is an anti-inflammatory drug that is used...
Current Pharmacological and Non-Pharmacological Treatments of Panic Disorder/Agoraphobia
Anxiety disorders represent the most prevalent psychiatric disorders, however, many patients who might benefit from treatment are not diagnosed or treated. This may partly be due to lack of awareness of the anxiety disor...